Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Klaus Wiedemann

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Double-Blind Method

Anatomy

Physiology

Sleep

Concepts & Ideas

Circadian Rhythm

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
35
Jahn, Holger
33
Holsboer, Florian
28
Kellner, Michael
25
Yassouridis, Alexander
24
Kiefer, Falk
17
Kellner, M
13
Otte, Christian
12
Raedler, Thomas
11
Naber, Dieter
9
Schick, Mildred
6
Steiger, Axel
6
Knaudt, K
6
Arlt, Josef
5
Ströhle, Andreas
5
Wolf, Karsten

Sign-in to see all Coauthors

Publications

TOP 3
Hinkelmann Kim; Moritz Steffen; Botzenhardt Johannes; Riedesel Kirsten; Wiedemann Klaus; Kellner Michael; Otte Christian
Cognitive impairment in major depression: association with salivary cortisol.
Kellner Michael; Muhtz Christoph; Demiralay Cüneyt; Husemann Jana; Koelsch Wiebke; Yassouridis Alexander; Wiedemann Klaus
The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
Kellner Michael; Demiralay Cüneyt; Muhtz Christoph; Husemann Jana; Kölsch Wiebke; Hiemke Christoph; Yassouridis Alexander; Wiedemann Klaus
No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Klaus Wiedemann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hinkelmann Kim; Moritz Steffen; Botzenhardt Johannes; Riedesel Kirsten; Wiedemann Klaus; Kellner Michael; Otte Christian
Cognitive impairment in major depression: association with salivary cortisol.
Biological psychiatry 2009;66(9):879-85.
2009: Kellner Michael; Muhtz Christoph; Demiralay Cüneyt; Husemann Jana; Koelsch Wiebke; Yassouridis Alexander; Wiedemann Klaus
The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
Journal of psychiatric research 2009;43(6):642-8.
2008: Kellner Michael; Demiralay Cüneyt; Muhtz Christoph; Husemann Jana; Kölsch Wiebke; Hiemke Christoph; Yassouridis Alexander; Wiedemann Klaus
No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter.
Psychiatry research 2008;161(3):339-43.
2008: Arlt S; Burkhardt D; Wiedemann K
Thyrotoxicosis after iodine contrast medium administration: rapid mood swing to mania and subsequent psychotic depression in a patient with bipolar disorder during lithium therapy.
Pharmacopsychiatry 2008;41(4):163-5.
2008: Muhtz Christoph; Wester Monika; Yassouridis Alexander; Wiedemann Klaus; Kellner Michael
A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
Journal of psychiatric research 2008;42(8):689-93.
2008: Kellner Michael; Wiedemann Klaus
Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy.
European journal of pharmacology 2008;583(2-3):372-8.
2008: Raedler Thomas J; Wittke Stefan; Jahn Holger; Koessler Andreas; Mischak Harald; Wiedemann Klaus
Capillary electrophoresis mass spectrometry as a potential tool to detect lithium-induced nephropathy: Preliminary results.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(3):673-8.
2007: Raedler Thomas J; Reimer Jens; Wiedemann Klaus
Dose-dependent constipation with higher doses of quetiapine: a case series.
International clinical psychopharmacology 2007;22(4):244-6.
2007: Otte Christian; Moritz Steffen; Yassouridis Alexander; Koop Maike; Madrischewski Ana Maria; Wiedemann Klaus; Kellner Michael
Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(1):232-8.
2007: Raedler Thomas J; Wiedemann Klaus
Lithium-induced nephropathies.
Psychopharmacology bulletin 2007;40(2):134-49.
2007: Raedler Thomas J; Schreiner Andreas; Naber Dieter; Wiedemann Klaus
Early onset of treatment effects with oral risperidone.
BMC psychiatry 2007;7():4.
2006: Otte Christian; Muhtz Christoph; Daneshkhah Sima; Yassouridis Alexander; Kiefer Falk; Wiedemann Klaus; Kellner Michael
Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
Biological psychiatry 2006;60(7):784-7.
2006: Raedler T J; Schreiner A; Naber D; Wiedemann K
Gender-specific effects in the treatment of acute schizophrenia with risperidone.
Pharmacopsychiatry 2006;39(5):171-4.
2006: Kiefer Falk; Jahn Holger; Otte Christian; Nakovics Helmut; Wiedemann Klaus
Effects of treatment with acamprosate on beta-endorphin plasma concentration in humans with high alcohol preference.
Neuroscience letters 2006;404(1-2):103-6.
2006: Kiefer Falk; Jahn Holger; Otte Christian; Naber Dieter; Wiedemann Klaus
Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
Biological psychiatry 2006;60(1):74-6.
2006: Raedler Thomas J; Wiedemann Klaus
CSF-studies in neuropsychiatric disorders.
Neuro endocrinology letters 2006;27(3):297-305.
2006: Wolf Karsten; Mass Reinhard; Kiefer Falk; Wiedemann Klaus; Naber Dieter
Characterization of the facial expression of emotions in schizophrenia patients: preliminary findings with a new electromyography method.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(6):335-41.
2006: Raedler Thomas J; Jahn Holger; Goedeken Birgit; Gescher Dorothee M; Kellner Michael; Wiedemann Klaus
Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
Depression and anxiety 2006;23(3):139-44.
2005: Wolf Karsten; Mass Reinhard; Ingenbleek Thomas; Kiefer Falk; Naber Dieter; Wiedemann Klaus
The facial pattern of disgust, appetence, excited joy and relaxed joy: an improved facial EMG study.
Scandinavian journal of psychology 2005;46(5):403-9.
2005: Kiefer Falk; Jahn Holger; Otte Christian; Demiralay Cüneyt; Wolf Karsten; Wiedemann Klaus
Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholism.
Journal of psychiatric research 2005;39(5):545-51.
2005: Wolf Karsten; Mass Reinhard; Kiefer Falk; Eckert Kirsten; Stritzky Alexandra V; Haasen Christian; Wiedemann Klaus; Naber Dieter
The influence of olanzapine versus risperidone on facial expression of emotions in schizophrenia--preliminary results of a facial electromyogram study.
Journal of clinical psychopharmacology 2005;25(3):278-81.
2005: Kellner Michael; Muhtz Christoph; Stark Kristina; Yassouridis Alexander; Arlt Josef; Wiedemann Klaus
Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
Psychopharmacology 2005;179(1):310-5.
2005: Kiefer Falk; Helwig Hauke; Tarnaske Timo; Otte Christian; Jahn Holger; Wiedemann Klaus
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
European addiction research 2005;11(2):83-91.
2005: Wolf Karsten; Raedler Thomas; Henke Kai; Kiefer Falk; Mass Reinhard; Quante Markus; Wiedemann Klaus
The face of pain--a pilot study to validate the measurement of facial pain expression with an improved electromyogram method.
Pain research & management : the journal of the Canadian Pain Society = journal de la société canadienne pour le traitement de la douleur 2005;10(1):15-9.
2004: Jahn Holger; Schick Mildred; Kiefer Falk; Kellner Michael; Yassouridis Alexander; Wiedemann Klaus
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Archives of general psychiatry 2004;61(12):1235-44.
2004: Kellner Michael; Schick Mildred; Yassouridis Alexander; Struttmann Tobias; Wiedemann Klaus; Alm Barbara
Metyrapone tests in patients with panic disorder.
Biological psychiatry 2004;56(11):898-900.
2004: Kiefer Falk; Wiedemann Klaus
Combined therapy: what does acamprosate and naltrexone combination tell us?
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(6):542-7.
2004: Kiefer F; Wiedemann K
Neuroendocrine pathways of addictive behaviour.
Addiction biology 2004;9(3-4):205-12.
2004: Raedler Thomas J; Jahn Holger; Arlt Josef; Kiefer Falk; Schick Mildred; Naber Dieter; Wiedemann Klaus
Adjunctive use of reboxetine in schizophrenia.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(6):366-9.
2004: Kellner Michael; Otte Christian; Yassouridis Alexander; Schick Mildred; Jahn Holger; Wiedemann Klaus
Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(4):337-9.
2004: Raedler Thomas J; Schreiner Andreas; Naber Dieter; Wiedemann Klaus
Risperidone in the treatment of acute schizophrenia.
Journal of clinical psychopharmacology 2004;24(3):335-8.
2004: Otte Christian; Wiedemann Klaus; Yassouridis Alexander; Kellner Michael
Valproate monotherapy in the treatment of civilian patients with non-combat-related posttraumatic stress disorder: an open-label study.
Journal of clinical psychopharmacology 2004;24(1):106-8.
2003: Arlt Josef; Jahn Holger; Kellner Michael; Ströhle Andreas; Yassouridis Alexander; Wiedemann Klaus
Modulation of sympathetic activity by corticotropin-releasing hormone and atrial natriuretic peptide.
Neuropeptides 2003;37(6):362-8.
2003: Raedler Thomas J; Jahn Holger; Goedeken Birgit; Gescher Dorothee M; Kellner Michael; Wiedemann Klaus
Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis.
Cancer chemotherapy and pharmacology 2003;52(6):482-6.
2003: Jahn Holger; Kiefer Falk; Schick Mildred; Yassouridis Alexander; Steiger Axel; Kellner Michael; Wiedemann Klaus
Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyrapone.
Sleep 2003;26(7):823-9.
2003: Otte Christian; Yassouridis Alexander; Jahn Holger; Maass Philipp; Stober Nina; Wiedemann Klaus; Kellner Michael
Mineralocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in aged humans.
The journals of gerontology. Series A, Biological sciences and medical sciences 2003;58(10):B900-5.
2003: Otte Christian; Jahn Holger; Yassouridis Alexander; Arlt Josef; Stober Nina; Maass Philip; Wiedemann Klaus; Kellner Michael
The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone.
Life sciences 2003;73(14):1835-45.
2003: Kellner Michael; Jahn Holger; Wiedemann Klaus
Natriuretic peptides and panic disorder: therapeutic prospects.
Expert review of neurotherapeutics 2003;3(3):381-6.
2003: Kiefer Falk; Jahn Holger; Koester Anja; Montkowski Alexandra; Reinscheid Rainer K; Wiedemann Klaus
Involvement of NMDA receptors in alcohol-mediated behavior: mice with reduced affinity of the NMDA R1 glycine binding site display an attenuated sensitivity to ethanol.
Biological psychiatry 2003;53(4):345-51.
2003: Kiefer Falk; Jahn Holger; Tarnaske Timo; Helwig Hauke; Briken Peer; Holzbach Rüdiger; Kämpf Philipp; Stracke Robert; Baehr Michael; Naber Dieter; Wiedemann Klaus
Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study.
Archives of general psychiatry 2003;60(1):92-9.
2003: Kellner Michael; Yassouridis Alexander; Hübner Renate; Baker Dewleen G; Wiedemann Klaus
Endocrine and cardiovascular responses to corticotropin-releasing hormone in patients with posttraumatic stress disorder: a role for atrial natriuretic peptide?
Neuropsychobiology 2003;47(2):102-8.
2002: Kellner Michael; Baker Dewleen G; Yassouridis Alexander; Bettinger Silke; Otte Christian; Naber Dieter; Wiedemann Klaus
Mineralocorticoid receptor function in patients with posttraumatic stress disorder.
The American journal of psychiatry 2002;159(11):1938-40.
2002: Kiefer Falk; Jahn Holger; Schick Mildred; Wiedemann Klaus
Alcohol self-administration, craving and HPA-axis activity: an intriguing relationship.
Psychopharmacology 2002;164(2):239-40.
2002: Kiefer Falk; Horntrich Mirko; Jahn Holger; Wiedemann Klaus
Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency?
Psychopharmacology 2002;162(4):433-7.
2002: Kellner Michael; Yassouridis Alexander; Hua Yun; Wendrich Mona; Naber Dieter; Wiedemann Klaus
Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man.
Psychiatry research 2002;111(1):93-6.
2002: Kiefer F; Jahn H; Schick M; Wiedemann K
Alcohol intake, tumour necrosis factor-alpha, leptin and craving: factors of a possibly vicious circle?
Alcohol and alcoholism (Oxford, Oxfordshire) 2002;37(4):401-4.
2002: Otte Christian; Kellner Michael; Arlt Josef; Jahn Holger; Holsboer Florian; Wiedemann Klaus
Prolactin but not ACTH increases during sodium lactate-induced panic attacks.
Psychiatry research 2002;109(2):201-5.
2002: Kellner Michael; Yehuda Rachel; Arlt Josef; Wiedemann Klaus
Longitudinal course of salivary cortisol in post-traumatic stress disorder.
Acta psychiatrica Scandinavica 2002;105(2):153-5; discussion 155-6.
2002: Kiefer F; Andersohn F; Jahn H; Wolf K; Raedler T J; Wiedemann K
Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal.
Acta psychiatrica Scandinavica 2002;105(1):65-70.
2002: Kellner M; Yassouridis A; Hua Y; Wendrich M; Jahn H; Wiedemann K
Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men.
Journal of psychiatric research 2002;36(1):1-6.
2001: Ströhle A; Kellner M; Holsboer F; Wiedemann K
Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder.
The American journal of psychiatry 2001;158(9):1514-6.
2001: Kellner M; Schick M; Wiedemann K
Prodissociative effects of metyrapone.
The American journal of psychiatry 2001;158(7):1159.
2001: Jahn H; Kiefer F; Behl C; Wiedemann K
Activation of guanylate cyclase by natriuretic peptides in mouse pituitary AtT20 cells is influenced by phosphorylation of ANP.
Neurochemical research 2001;26(5):473-8.
2001: Kiefer F; Jahn H; Wolf K; Kämpf P; Knaudt K; Wiedemann K
Free-choice alcohol consumption in mice after application of the appetite regulating peptide leptin.
Alcoholism, clinical and experimental research 2001;25(5):787-9.
2001: Kiefer F; Jahn H; Jaschinski M; Holzbach R; Wolf K; Naber D; Wiedemann K
Leptin: a modulator of alcohol craving?
Biological psychiatry 2001;49(9):782-7.
2001: Wiedemann K; Jahn H; Yassouridis A; Kellner M
Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
Archives of general psychiatry 2001;58(4):371-7.
2001: Jahn H; Montkowski A; Knaudt K; Ströhle A; Kiefer F; Schick M; Wiedemann K
Alpha-helical-corticotropin-releasing hormone reverses anxiogenic effects of C-type natriuretic peptide in rats.
Brain research 2001;893(1-2):21-8.
2000: Kellner M; Wiedemann K; Yassouridis A; Levengood R; Guo L S; Holsboer F; Yehuda R
Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder.
Biological psychiatry 2000;47(2):107-11.
2000: Kiefer F; Kellner M; Jahn H; Wiedemann K
Comparison of the effects of endothelin-1 and -3 on secretion of pituitary hormones in healthy male volunteers.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(5):378-81.
2000: Wiedemann K; Jahn H; Kellner M
Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2000;108(1):5-13.
1999: Ströhle A; Kellner M; Holsboer F; Wiedemann K
Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
Biological psychiatry 1999;45(3):321-6.
1998: Wiedemann K; Hirschmann M; Knaudt K; Rupprecht R; Seier F E; Holsboer F
Sleep endocrine effects of megestrol acetate in healthy men.
Journal of neuroendocrinology 1998;10(9):719-27.
1998: Kellner M; Levengood R; Yehuda R; Wiedemann K
Provocation of a posttraumatic flashback by cholecystokinin tetrapeptide?
The American journal of psychiatry 1998;155(9):1299.
1998: Montkowski A; Jahn H; Ströhle A; Poettig M; Holsboer F; Wiedemann K
C-type natriuretic peptide exerts effects opposing those of atrial natriuretic peptide on anxiety-related behaviour in rats.
Brain research 1998;792(2):358-60.
1998: Ströhle A; Kellner M; Yassouridis A; Holsboer F; Wiedemann K
Effect of flumazenil in lactate-sensitive patients with panic disorder.
The American journal of psychiatry 1998;155(5):610-2.
1998: Ströhle A; Kellner M; Holsboer F; Wiedemann K
Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test.
Biological psychiatry 1998;43(5):371-5.
1998: Kellner M; Knaudt K; Jahn H; Holsboer F; Wiedemann K
Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences.
Journal of psychiatric research 1998;32(1):37-48.
1998: Wiedemann K; Lauer C J; Hirschmann M; Knaudt K; Holsboer F
Sleep-endocrine effects of mifepristone and megestrol acetate in healthy men.
The American journal of physiology 1998;274(1 Pt 1):E139-45.
1997: Wiedemann K; Holsboer F
The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects.
Biological psychiatry 1997;42(10):882-8.
1997: Kellner M; Yassouridis A; Jahn H; Wiedemann K
Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
Psychopharmacology 1997;133(1):55-61.
1997: Frieboes R M; Murck H; Wiedemann K; Holsboer F; Steiger A
Open clinical trial on the sigma ligand panamesine in patients with schizophrenia.
Psychopharmacology 1997;132(1):82-8.
1997: Kellner M; Wiedemann K; Zihl J
Illumination perception in photophobic patients suffering from panic disorder with agoraphobia.
Acta psychiatrica Scandinavica 1997;96(1):72-4.
1997: Seier F E; Kellner M; Yassouridis A; Heese R; Strian F; Wiedemann K
Autonomic reactivity and hormonal secretion in lactate-induced panic attacks.
The American journal of physiology 1997;272(6 Pt 2):H2630-8.
1997: Kellner M; Diehl I; Knaudt K; Schüle C; Jahn H; Wiedemann K
C-type natriuretic peptide exerts stimulatory effects on the corticotropin-releasing hormone-induced secretion of hormones in normal man.
European journal of endocrinology / European Federation of Endocrine Societies 1997;136(4):388-93.
1997: Kellner M; Yassouridis A; Manz B; Steiger A; Holsboer F; Wiedemann K
Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers--a potential link to low-melatonin syndrome in depression?
Neuroendocrinology 1997;65(4):284-90.
1997: Ströhle A; Jahn H; Montkowski A; Liebsch G; Boll E; Landgraf R; Holsboer F; Wiedemann K
Central and peripheral administration of atriopeptin is anxiolytic in rats.
Neuroendocrinology 1997;65(3):210-5.
1996: Ströhle A; Wiedemann K
Flumazenil attenuates the pituitary response to CRH in healthy males.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6(4):323-5.
1996: Murck H; Guldner J; Colla-Müller M; Frieboes R M; Schier T; Wiedemann K; Holsboer F; Steiger A
VIP decelerates non-REM-REM cycles and modulates hormone secretion during sleep in men.
The American journal of physiology 1996;271(4 Pt 2):R905-11.
1996: Kellner M; Hirschmann M; Wiedemann K
Panic attacks caused by temporal tumors: an exemplary new case and a review.
Depression and anxiety 1996;4(5):243-5.
1995: Kellner M; Herzog L; Yassouridis A; Holsboer F; Wiedemann K
Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic.
The American journal of psychiatry 1995;152(9):1365-7.
1995: Wiedemann K; Herzog L; Kellner M
Atrial natriuretic hormone inhibits corticotropin-releasing hormone-induced prolactin release in man.
Journal of psychiatric research 1995;29(1):51-8.
1995: Kellner M; Herzog L; Holsboer F; Wiedemann K
Circadian changes in the sensitivity of the corticotropin-releasing hormone-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls.
Psychoneuroendocrinology 1995;20(5):515-24.
1995: Friess E; Wiedemann K; Steiger A; Holsboer F
The hypothalamic-pituitary-adrenocortical system and sleep in man.
Advances in neuroimmunology 1995;5(2):111-25.
1994: Holsboer F; Grasser A; Friess E; Wiedemann K
Steroid effects on central neurons and implications for psychiatric and neurological disorders.
Annals of the New York Academy of Sciences 1994;746():345-59; discussion 359-61.
1994: Wiedemann K; Lauer C; Pollmächer T; Holsboer F
Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males.
The American journal of physiology 1994;267(1 Pt 1):E109-14.
1994: Wiedemann K; Kellner M
Endocrine characterization of the new dopamine autoreceptor agonist roxindole.
Experimental and clinical endocrinology 1994;102(4):284-8.
1993: Schreiber W; Pollmächer T; Fassbender K; Gudewill S; Vedder H; Wiedemann K; Galanos C; Holsboer F
Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol. A comparative study in men.
Neuroendocrinology 1993;58(1):123-8.
1993: Pollmächer T; Schreiber W; Gudewill S; Vedder H; Fassbender K; Wiedemann K; Trachsel L; Galanos C; Holsboer F
Influence of endotoxin on nocturnal sleep in humans.
The American journal of physiology 1993;264(6 Pt 2):R1077-83.
1992: Garcia-Borreguero D; Lauer C J; Ozdaglar A; Wiedemann K; Holsboer F; Krieg J C
Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A.
Pharmacopsychiatry 1992;25(6):261-4.
1992: Steiger A; Guldner J; Hemmeter U; Rothe B; Wiedemann K; Holsboer F
Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls.
Neuroendocrinology 1992;56(4):566-73.
1992: Wiedemann K; Lauer C; Loycke A; Pollmächer T; Durst P; Machér J P; Holsboer F
Antiglucocorticoid treatment disrupts endocrine cycle and nocturnal sleep pattern.
European archives of psychiatry and clinical neuroscience 1992;241(6):372-5.
1992: Kellner M; Wiedemann K; Holsboer F
Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man.
Life sciences 1992;50(24):1835-42.
1991: Wiedemann K; von Bardeleben U; Holsboer F
Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion.
Neuroendocrinology 1991;54(5):462-8.
1991: Steiger A; von Bardeleben U; Wiedemann K; Holsboer F
Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission.
Journal of psychiatric research 1991;25(4):169-77.
1991: Wetzel H; Wiedemann K; Holsboer F; Benkert O
Savoxepine: invalidation of an "atypical" neuroleptic response pattern predicted by animal models in an open clinical trial with schizophrenic patients.
Psychopharmacology 1991;103(2):280-3.
1990: Banger M; Hiemke C; Knuppen R; Ball P; Haupt M; Wiedemann K
Formation and metabolism of catecholestrogens in depressed patients.
Biological psychiatry 1990;28(8):685-96.
1989: Maier W; Philipp M; Schlegel S; Heuser I; Wiedemann K; Benkert O
Diagnostic determinants of response to treatment with tricyclic antidepressants: a polydiagnostic approach.
Psychiatry research 1989;30(1):83-93.
1989: Schlegel S; von Bardeleben U; Wiedemann K; Frommberger U; Holsboer F
Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.
Psychoneuroendocrinology 1989;14(3):209-16.
1988: von Bardeleben U; Wiedemann K; Stalla G K; Müller O A; Holsboer F
Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment.
Biological psychiatry 1988;24(3):331-5.
1987: Wiedemann K; Holsboer F
Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
Biological psychiatry 1987;22(11):1340-8.
1986: Holsboer F; Wiedemann K; Gerken A; Boll E
The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.
Psychiatry research 1986;17(2):97-103.

Sign-in to see more